Stay updated on Pembrolizumab in Pediatric Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe site revision label changed from v3.7.0 to v3.7.1 while the study page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking access to the study record content. This resembles a permissions/server issue rather than a substantive update to the study data.SummaryDifference22%

- Check22 days agoChange DetectedThe UI now displays the label 'Find contact information' with a lower-case 'c' and shows a new 'Revision: v3.7.0' tag, replacing the previous 'Find Contact Information' and 'Revision: v3.6.6' text. These are cosmetic updates indicating a new page revision rather than substantive content changes.SummaryDifference0.1%

- Check37 days agoChange DetectedThe revision label at the bottom of the page was updated from v3.6.5 to v3.6.6, indicating a new iteration of the page. No substantive changes to the study details are implied.SummaryDifference0.0%

- Check44 days agoChange DetectedAdded a line '2014 ( U.S. NIH Grant/Contract )' under Other Study ID Numbers. This records NIH funding as part of the study's identifiers.SummaryDifference0.0%

- Check58 days agoChange DetectedA new page revision tag Revision: v3.6.5 was added, and the Plain Language Summary along with the older Revision: v3.6.4 were removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Pediatric Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pediatric Solid Tumors Clinical Trial page.